| Product NDC: | 25021-655 |
| Proprietary Name: | Midazolam |
| Non Proprietary Name: | midazolam hydrochloride |
| Active Ingredient(s): | 1 mg/mL & nbsp; midazolam hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-655 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090315 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120319 |
| Package NDC: | 25021-655-05 |
| Package Description: | 10 VIAL in 1 CARTON (25021-655-05) > 5 mL in 1 VIAL |
| NDC Code | 25021-655-05 |
| Proprietary Name | Midazolam |
| Package Description | 10 VIAL in 1 CARTON (25021-655-05) > 5 mL in 1 VIAL |
| Product NDC | 25021-655 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | midazolam hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20120319 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | MIDAZOLAM HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |